Cargando…
ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications
Hepatocellular carcinoma (HCC), a representative example of a malignancy with a poor prognosis, is characterized by high mortality because it is typically in an advanced stage at diagnosis and leaves very little hepatic functional reserve. Despite advances in medical and surgical techniques, there i...
Autores principales: | Lee, Danbi, Jang, Myoung-Kuk, Seo, Ji Hae, Ryu, Soo Hyung, Kim, Jeong A., Chung, Young-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063946/ https://www.ncbi.nlm.nih.gov/pubmed/30054466 http://dx.doi.org/10.1038/s12276-018-0106-1 |
Ejemplares similares
-
Versatility of ARD1/NAA10-mediated protein lysine acetylation
por: Vo, Tam Thuy Lu, et al.
Publicado: (2018) -
Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10
por: Vo, Tam Thuy Lu, et al.
Publicado: (2020) -
ARD1/NAA10 acetylation in prostate cancer
por: Kuhns, Katherine J., et al.
Publicado: (2018) -
Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway
por: Kweon, Hyae Yon, et al.
Publicado: (2021) -
NAA10 as a New Prognostic Marker for Cancer Progression
por: Kim, Sun Myung, et al.
Publicado: (2020)